Stamibio Beauty - Dermocosmetic Anti-aging cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, BIO-PLEX RNA, OLIGOELEMENTI, JOJOBA OIL, RHODIOLA ROSEA, GINSENG, GUARANÀ, OENOTHERA BIENNIS, Coenzyme Q10 (Ubiquinone)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Lotion Dermocosmetic Restructuring Lotion

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GINGKO BILOBA, SALVIA OFFICINALIS, VITAMIN E
Other information: Lotion

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Calmderm Fluid dermocosmetic cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GLYCYRRHETINIC ACID , VITAMIN E , PROVITAMIN D , BOSWELLIA SERRATA, LECITHIN, ZANTHALENE, CALMING AGENT (SYMSITIVE)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Derm Skin-protecting dermocosmetic cream

Marketed by: GUNA
Active ingredient: Roe extract, Glycyrrhetinic acid, Vitamin E (Tocopheryl acetate), 7-Dehydrocholesterol ,Boswellia serrata, Zanthoxylum alatum
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Serum Dermocosmetic serum

Marketed by: GUNA
Active ingredient: ROE EXTRACT, HIGH MOLECULAR WEIGHT HYALURONIC ACID, INOSITOL, HOP EXTRACT, COCOA EXTRACT, GINSENG, GUARANÀ,LOTUS EXTRACT, HYDROLYZED DNA AND RNA, MACA EXTRACT, TRACE ELEMENTS, ANTI-SPOT COMPLEX
Other information: Serum

Available in: Italy
Language: English
Source: myHealthbox

Rasilez 150 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren
Other information: Film-coated tablet - 150 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 150 mg/12.5 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 150 mg aliskiren (as hemifumarate) and 12.5 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 150 mg/25 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 150 mg aliskiren (as hemifumarate) and 25 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 300 mg/12.5 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 300 mg aliskiren (as hemifumarate) and 12.5 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Eliquis 2.5 mg film-coated tablets

Marketed by: Bristol-Myers Squibb, Pfizer EEIG
Active ingredient: Apixaban
Other information: Film-coated tablet - 2.5 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 300 units/ml solution for injection in a pre-filled pen

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 300 units insulin glargine (equivalent to 10.91 mg). Each pen contains 1.5 ml of solution for injection, equiva

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a vial

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine* (equivalent to 3.64 mg). Each vial contains 5 ml of solution for injection, equival

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a cartridge

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine (equivalent to 3.64 mg). Each cartridge contains 3 ml of solution for injection, equ

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a cartridge for OptiClik

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine (equivalent to 3.64 mg). Each cartridge contains 3 ml of solution for injection, equ

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo OptiSet 100 units/ml solution for injection in a pre-filled pen

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine (equivalent to 3.64 mg). Each pen contains 3 ml of solution for injection, equivalen

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Klacid Forte 500mg Film-coated Tablets

Marketed by: BGP Products Ireland Limited
Active ingredient: Clarithromycin
Other information: Film-coated Tablet - 500 mg

Available in: Ireland
Language: English
Source: myHealthbox

Amitriptyline hydrochloride 10mg/5ml Oral solution

Marketed by: Syri Limited t/a Thame Laboratories
Active ingredient: Amitriptyline hydrochloride
Other information: Oral Solution - 10 MG/5ml

Available in: Ireland
Language: English
Source: myHealthbox

9-12-2015

Orphan designation: Imatinib mesilate, for the: Treatment of myelodysplastic / myeloproliferative diseases

On 23 December 2005, orphan designation (EU/3/05/340) was granted by the European Commission Novartis Europharm Limited, United Kingdom, for imatinib mesilate for the treatment of myelodysplastic / myeloproliferative diseases. Please note that this product...

Europe - EMA - European Medicines Agency

29-6-2015

Orphan designation: Lenvatinib, for the: Treatment of papillary thyroid cancer

Europe - EMA - European Medicines Agency

29-6-2015

Orphan designation: Lenvatinib, for the: Treatment of follicular thyroid cancer

Europe - EMA - European Medicines Agency

29-6-2015

Fimea will bring in the Common Repository database on 1 July 2015

Fimea will bring in the Common Repository database on 1 July 2015 Fimea will introduce the Common Repository database of the European Medicines Agency starting from 1 July 2015. All national authorities will be simultaneously obliged to use the datab...

Finland - Fimea News

29-6-2015

News and press releases: Update on publication of clinical data

EMA publishes video and presentations from the 24 June webinar on the implementation of its transparency policy...

Europe - EMA - European Medicines Agency

29-6-2015

ZO SKIN HEALTH OFFECTS SULFUR MASQUE ACNE TREATMENT (Sulfur) Cream [ZO Skin Health, Inc.]

Updated Date: Jun 29, 2015 EST...

US - DailyMed

29-6-2015

CELECOXIB Capsule [Unit Dose Services]

Updated Date: Jun 29, 2015 EST...

US - DailyMed

29-6-2015

TINTED MOISTURIZER SPF-20 (Titanium Dioxide, Zinc Oxide) Lotion [HATCHBEAUTY PRODUCTS LLC]

Updated Date: Jun 29, 2015 EST...

US - DailyMed

29-6-2015

SMOOTHING MINERAL PRIMER SPF-15 (Titanium Dioxide) Lotion [HATCHBEAUTY PRODUCTS LLC]

Updated Date: Jun 29, 2015 EST...

US - DailyMed

29-6-2015

PAIN RELIEF CHILDRENS (Acetaminophen) Suspension [Publix Super Markets Inc]

Updated Date: Jun 29, 2015 EST...

US - DailyMed

29-6-2015

EQUALINE NICOTINE (Nicotine Polacrilex) Lozenge [Supervalu Inc]

Updated Date: Jun 29, 2015 EST...

US - DailyMed